Article

Identification of Biomarker Signatures and Candidate Drugs in Non-Small Cell Lung Cancer

2019-07-03

Abstract excerpt

Lung cancer is one of the most important health risks worldwide for human. Non-small cell lung cancer (NSCLC) is the most common cause of premature death from malignant disease. This study provides in-depth insights from systems biology analyses to identify molecular to inform systemic drug targeting in NSCLC. Gene expression profiles from non small cell lung cancer were analyzed with genome-scale biomolecular net...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 978e62f7-e41c-536e-9a87-52cba2469760
DOI: 10.20944/preprints201907.0051.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Biomarker Signatures and Candidate Drugs in Non-Small Cell Lung CancerDOI 10.20944/preprints201907.0051.v1Read

Integrated Multi-Omics Analysis Identifies Key Genes and Drug Candidates in Non-Small Cell Lung CancerSemantic proximity Read

Identification of 10 Important Genes with Poor Prognosis in Non-small cell Lung Cancer through Bioinformatical AnalysisSemantic proximity Read

Network-based Identification of Key Proteins and Repositioning of Drugs for Non-Small Cell Lung CancerSemantic proximity Read

Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges.Semantic proximity Read

Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancerSemantic proximity Read

Bioinformatics-based prognostic analysis of non-small cell lung cancerSemantic proximity Read

Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studiesSemantic proximity Read

Identification of differentially expressed genes in non-small cell lung cancerSemantic proximity Read

Regulatory Network Analysis to Reveal Important miRNAs and Genes in Non-Small Cell Lung Cancer.Semantic proximity Read

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung CancerSemantic proximity Read

Identidication of novel biomarkers in non-small cell lung cancer using machine learningSemantic proximity Read

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics AnalysisSemantic proximity Read